Template:ID-Parasitic meningitis: Difference between revisions

Jump to navigation Jump to search
mNo edit summary
mNo edit summary
Line 19: Line 19:
:::* Alternative regimen: [[Thiabendazole]] 50 mg/kg/day PO bid for 10 days {{and}} [[Dexamethasone]] 10–20 mg PO qd for 10 days
:::* Alternative regimen: [[Thiabendazole]] 50 mg/kg/day PO bid for 10 days {{and}} [[Dexamethasone]] 10–20 mg PO qd for 10 days


::* '''Gnathostoma spinigerum'''
::* '''Gnathostoma spinigerum'''<ref>{{Cite journal| doi = 10.1128/CMR.00003-09| issn = 1098-6618| volume = 22| issue = 3| pages = 484–492| last1 = Herman| first1 = Joanna S.| last2 = Chiodini| first2 = Peter L.| title = Gnathostomiasis, another emerging imported disease| journal = Clinical Microbiology Reviews| date = 2009-07| pmid = 19597010| pmc = PMC2708391}}</ref><ref>{{Cite journal| doi = 10.1086/595852| issn = 1537-6591| volume = 48| issue = 3| pages = 322–327| last1 = Ramirez-Avila| first1 = Lynn| last2 = Slome| first2 = Sally| last3 = Schuster| first3 = Frederick L.| last4 = Gavali| first4 = Shilpa| last5 = Schantz| first5 = Peter M.| last6 = Sejvar| first6 = James| last7 = Glaser| first7 = Carol A.| title = Eosinophilic meningitis due to Angiostrongylus and Gnathostoma species| journal = Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America| date = 2009-02-01| pmid = 19123863}}</ref>
:::* Preferred regimen: [[Albendazole]] 400 mg PO bid for 3 weeks {{and}} [[Dexamethasone]] 10–20 mg PO qd for 3 weeks
:::* Preferred regimen: [[Albendazole]] 400 mg PO bid for 3 weeks {{and}} [[Dexamethasone]] 10–20 mg PO qd for 3 weeks
:::* Alternative regimen: [[Ivermectin]] 0.2 mg/kg PO qd for 2 days {{and}} [[Dexamethasone]] 10–20 mg PO qd for 3 weeks
:::* Alternative regimen: [[Ivermectin]] 0.2 mg/kg PO qd for 2 days {{and}} [[Dexamethasone]] 10–20 mg PO qd for 3 weeks
Adapted from Clin Microbiol Rev. 2009;22(3):484-92. and Clin Infect Dis. 2009;48(3):322-7.[16][13]

Revision as of 00:11, 20 June 2015

  • Meningitis, parasitic
  • Protozoal meningitis
  • Naegleria fowleri (primary amebic meningoencephalitis)[1][2]
  • Toxoplasma gondii[3]
  • Helminthic meningitis
  • Angiostrongylus cantonensis[4][5]
  • Preferred regimen: Albendazole 15–20 mg/kg/day PO qd–bid for 10–20 days AND Dexamethasone 10–20 mg PO qd for 10–20 days
  • Alternative regimen: Mebendazole 100 mg PO bid for 10–20 days AND Dexamethasone 10–20 mg PO qd for 10–20 days
  1. Linam, W. Matthew; Ahmed, Mubbasheer; Cope, Jennifer R.; Chu, Craig; Visvesvara, Govinda S.; da Silva, Alexandre J.; Qvarnstrom, Yvonne; Green, Jerril (2015-03). "Successful treatment of an adolescent with Naegleria fowleri primary amebic meningoencephalitis". Pediatrics. 135 (3): –744-748. doi:10.1542/peds.2014-2292. ISSN 1098-4275. PMID 25667249. Check date values in: |date= (help)
  2. Vargas-Zepeda, Jesús; Gómez-Alcalá, Alejandro V.; Vásquez-Morales, José Alfonso; Licea-Amaya, Leonardo; De Jonckheere, Johan F.; Lares-Villa, Fernando (2005-02). "Successful treatment of Naegleria fowleri meningoencephalitis by using intravenous amphotericin B, fluconazole and rifampicin". Archives of Medical Research. 36 (1): 83–86. ISSN 0188-4409. PMID 15900627. Check date values in: |date= (help)
  3. Bennett, John (2015). Mandell, Douglas, and Bennett's principles and practice of infectious diseases. Philadelphia, PA: Elsevier/Saunders. ISBN 978-1455748013.
  4. Wang, Qiao-Ping; Lai, De-Hua; Zhu, Xing-Quan; Chen, Xiao-Guang; Lun, Zhao-Rong (2008-10). "Human angiostrongyliasis". The Lancet. Infectious Diseases. 8 (10): 621–630. doi:10.1016/S1473-3099(08)70229-9. ISSN 1473-3099. PMID 18922484. Check date values in: |date= (help)
  5. Ramirez-Avila, Lynn; Slome, Sally; Schuster, Frederick L.; Gavali, Shilpa; Schantz, Peter M.; Sejvar, James; Glaser, Carol A. (2009-02-01). "Eosinophilic meningitis due to Angiostrongylus and Gnathostoma species". Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America. 48 (3): 322–327. doi:10.1086/595852. ISSN 1537-6591. PMID 19123863.
  6. Gavin, Patrick J.; Kazacos, Kevin R.; Shulman, Stanford T. (2005-10). "Baylisascariasis". Clinical Microbiology Reviews. 18 (4): 703–718. doi:10.1128/CMR.18.4.703-718.2005. ISSN 0893-8512. PMC 1265913. PMID 16223954. Check date values in: |date= (help)
  7. Murray, William J.; Kazacos, Kevin R. (2004-11-15). "Raccoon roundworm encephalitis". Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America. 39 (10): 1484–1492. doi:10.1086/425364. ISSN 1537-6591. PMID 15546085.
  8. Herman, Joanna S.; Chiodini, Peter L. (2009-07). "Gnathostomiasis, another emerging imported disease". Clinical Microbiology Reviews. 22 (3): 484–492. doi:10.1128/CMR.00003-09. ISSN 1098-6618. PMC 2708391. PMID 19597010. Check date values in: |date= (help)
  9. Ramirez-Avila, Lynn; Slome, Sally; Schuster, Frederick L.; Gavali, Shilpa; Schantz, Peter M.; Sejvar, James; Glaser, Carol A. (2009-02-01). "Eosinophilic meningitis due to Angiostrongylus and Gnathostoma species". Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America. 48 (3): 322–327. doi:10.1086/595852. ISSN 1537-6591. PMID 19123863.